| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/AJCP5UAFMSA9ZQBZ |
| P698 | PubMed publication ID | 22706858 |
| P2093 | author name string | Haiyan Liu | |
| Fan Lin | |||
| Myra L Wilkerson | |||
| Jianhui Shi | |||
| P2860 | cites work | GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland | Q24649647 |
| Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer | Q24653339 | ||
| Essential role of Gata transcription factors in sympathetic neuron development | Q28509275 | ||
| Critical roles for transcription factor GATA-3 in thymocyte development | Q28511459 | ||
| GATA-3: an unexpected regulator of cell lineage determination in skin | Q28512924 | ||
| Transcription factor GATA-3 is required for development of the T-cell lineage | Q28587190 | ||
| Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney | Q28588295 | ||
| Higher levels of GATA3 predict better survival in women with breast cancer | Q34318251 | ||
| Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas | Q34508666 | ||
| Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation | Q34573593 | ||
| GATA Transcription Factors and Cancer | Q34972814 | ||
| Regulation of GATA gene expression during vertebrate development | Q36013984 | ||
| Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions | Q37580229 | ||
| Transcriptional control of T-cell development | Q37938910 | ||
| Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray | Q38302354 | ||
| Function of GATA transcription factors in preadipocyte-adipocyte transition | Q42835284 | ||
| Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus | Q45819596 | ||
| The significance of GATA3 expression in breast cancer: a 10-year follow-up study | Q46197423 | ||
| Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas | Q47174190 | ||
| Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. | Q51667599 | ||
| Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. | Q53508609 | ||
| PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues. | Q54702118 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 57-64 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas | |
| P478 | volume | 138 |
| Q98771548 | A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data |
| Q26796705 | Adenocarcinoma of the urinary bladder |
| Q57493732 | Aggressive Metastatic GATA3-Positive Sarcomatoid Carcinoma with Rapid Progression and Invasion of the Liver |
| Q90604719 | An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin |
| Q93012146 | Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer |
| Q92151226 | Breast metastasis from colorectal cancer treated by multimodal therapy: Case report and literature review |
| Q35789064 | Case report of gastric outlet obstruction from metastatic lobular breast carcinoma |
| Q53642057 | Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining. |
| Q26852127 | Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) |
| Q35087772 | Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma |
| Q50114127 | Differentiating Breast Carcinoma with Signet-Ring Features from Gastrointestinal Signet-Ring Carcinoma: Assessment of Immunohistochemical Markers |
| Q46835015 | Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers |
| Q89578757 | Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostate |
| Q90607732 | Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide |
| Q53599776 | Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung. |
| Q38819810 | Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysis |
| Q53427475 | GATA binding protein 3 expression is present in primitive patterns of yolk sac tumours but is not expressed by differentiated variants. |
| Q34714508 | GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility |
| Q50013621 | GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer |
| Q41615352 | GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry |
| Q36973436 | GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms |
| Q54239056 | GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse. |
| Q37709554 | GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas |
| Q52960719 | GATA3 expression in gestational trophoblastic tissues and tumours. |
| Q38191883 | GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases |
| Q51061485 | GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. |
| Q51502502 | GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia. |
| Q38716068 | GATA3 expression in triple-negative breast cancers. |
| Q39725001 | GATA3 immunohistochemical expression in invasive urothelial carcinoma. |
| Q42078661 | GATA3 immunohistochemical expression in salivary gland neoplasms |
| Q58617442 | GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors |
| Q45069242 | GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints. |
| Q40978489 | GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15. |
| Q37709857 | GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors |
| Q51168646 | GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. |
| Q58568627 | Gastric outlet obstruction caused by metastatic tumor of the stomach originating from primary breast cancer: A case report |
| Q55081282 | Gata3 Immunohistochemical Staining is A Useful Marker for Metastatic Breast Carcinoma in Fine Needle Aspiration Specimens. |
| Q60302089 | Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites |
| Q42509280 | Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5. |
| Q57793491 | Immunohistochemical Biomarkers in Thyroid Pathology |
| Q40276725 | Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment |
| Q55251613 | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site. |
| Q38362871 | Immunostaining in lung cancer for the clinician. Commonly used markers for differentiating primary and metastatic pulmonary tumors |
| Q98460931 | Isolated Metastasis to the Brain from Upper Tract Urothelial Carcinoma |
| Q37692460 | Loss of GATA3 in bladder cancer promotes cell migration and invasion. |
| Q38696793 | Markers of metastatic carcinoma of breast origin |
| Q46592018 | Metastatic metaplastic breast carcinoma mimicking pulmonary squamous cell carcinoma on fine-needle aspiration. |
| Q55177024 | Polymorphous adenocarcinoma of the oral cavity: A skeptical case mimicking lobular carcinoma of breast and gastric carcinoma. |
| Q33949858 | Similarity of GATA-3 Expression between Rat and Human Mammary Glands |
| Q92619208 | Simultaneous expression of TTF1 and GATA3 in a lung biopsy sample: confusion in diagnostic pathology |
| Q61805019 | Synchronous Ovarian and Breast Cancers with a Novel Variant in BRCA2 Gene: A Case Report |
| Q43529946 | TGFBR3 co-downregulated with GATA3 is associated with methylation of the GATA3 gene in bladder urothelial carcinoma |
| Q100431739 | TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer |
| Q41942838 | Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series. |
| Q57793471 | The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations |
| Q38438463 | The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors |
| Q38668780 | The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. |
| Q37411423 | Unsuspected Malignancy During Percutaneous Nephrolithotomy: The Snake in the Grass. |
| Q92713040 | Unusual Gastric Metastasis in Triple-Negative (Estrogen Receptor/Progesterone Receptor/HER2neu Negative) GATA-Binding Protein 3-Positive Breast Cancer |
| Q38658274 | Urothelial Superior Vena Cava Syndrome with Limited Response to Radiation Therapy |
| Q38576718 | Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective |
| Q38526035 | Use of Immunohistochemical Stains in Epithelial Lesions of the Breast |
| Q87635236 | Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens |
| Q87494494 | Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens |
| Q48324787 | Utility of GATA3 in the differential diagnosis of pheochromocytoma. |
| Q53312011 | Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions. |
Search more.